We posted an article about N-nitrosoamine risk assessments

January. 25, 2023

We posted an article about N-nitrosoamine risk assessments for oral dosage forms.

CeolusTM demonstrated a very low level of nitrite and nitrate that can allow mitigating nitrosamine formation in the drug products with secondary or tertiary amines.
Obtained results justified with Asahi Kasei Corp.’s manufacturing process features allow to do the evidence-based choice of MCC-grades with low nitrite content for the formulation of oral dosage form formulations with low nitrosamine-associated risk.

N-nitrosamine risk assessments for oral dosage forms: Nitrite content in the microcrystalline cellulose (MCC)
https://www.pharmaexcipients.com/news/nitrosamine-risk-assessments-mcc/

The full article is available Pharmaexcipients website.

N-nitrosamine risk assessments for oral dosage forms: Nitrite content in the microcrystalline cellulose (MCC)
TOP

Cookie Policy

We use Access Data (Data on devices that visitors to this website use) and Cookie (text files containing small amounts of information which will be downloaded to your device upon your visit to a website) of visitors to this website.
With regards to the handling of such data, we follow Asahi Kasei’s Cookie policy except for the followings. For clarity, “this website” in the aforementioned Cookie policy, shall include www.ceolus.com.

We use Access Data and Cookie obtained through this website for following purposes;
- For the purpose that is specified in 1.(1) Purpose of use in Asahi Kasei’s privacy policy.
- For the purpose of providing you with information concerning our products or business by direct mail or e-mail.
Such information may be provided to you by following Asahi Kasei group companies (hereunder “Asahi Kasei Group Companies”):

Analytical tool

This website uses Google Analytics, an analytical tool that is provided by Google Inc. Please go to Google Inc.’s website for their privacy policy and Cookie policy.

Outsourcing Contractor

With regards to Access Data and Cookie of visitors to this website that was provided upon user registration, Access Data and Cookie, moving forward to smoothly run our operations, Asahi Kasei and Asahi Kasei group companies may entrust a part of our operations to third party contractors and provide such third party contractors with Access Data and Cookie to the extent that is required. In such cases, Asahi Kasei and Asahi Kasei group companies shall adopt third party contractors that are appropriate to handle Access Data and Cookie, and set appropriate controls in place such as having agreement on handling of Access Data and Cookie in place with them.

If you have any questions or complaints for the handling of Personal Data, etc, and terms and conditions of this website, please contact followings:

Healthcare Materials Division
Asahi Kasei Corporation